{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:24:13Z","timestamp":1761513853516},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.semarthrit.2016.07.010","type":"journal-article","created":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T00:20:06Z","timestamp":1469924406000},"page":"473-487","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Measures of disease status in systemic sclerosis: A systematic review"],"prefix":"10.1016","volume":"46","author":[{"given":"Tien","family":"Tay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nava","family":"Ferdowsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna M.","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2016.07.010_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes","volume":"60","author":"Valentini","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/rheumatology\/keq022","article-title":"Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis","volume":"49","author":"Minier","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib3","first-page":"2159","article-title":"A disease severity scale for systemic sclerosis: Development and testing","volume":"26","author":"Medsger","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib4","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/ard.60.12.1117","article-title":"Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale","volume":"60","author":"Geirsson","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib6","first-page":"367","article-title":"Results of the Health Assessment Questionnaire for Japanese patients with systemic sclerosis\u2014measuring functional impairment in systemic sclerosis versus other connective tissue diseases","volume":"25","author":"Morita","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2133.1976.tb00855.x","article-title":"Thymus-dependent (T) lymphocyte deficiency in progressive systemic sclerosis","volume":"95","author":"Hughes","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/anr.1780320512","article-title":"Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study","volume":"32","author":"Furst","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/ard.46.10.763","article-title":"A new promising treatment in systemic sclerosis: 5-fluorouracil","volume":"46","author":"Casas","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/ard.2007.078923","article-title":"Development of a provisional core set of response measures for clinical trials of systemic sclerosis","volume":"67","author":"Khanna","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/art.23718","article-title":"Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: A delphi consensus study with cluster analysis","volume":"59","author":"Distler","year":"2008","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib12","first-page":"198","article-title":"The OMERACT filter for outcome measures in rheumatology","volume":"25","author":"Boers","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib14","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2622","article-title":"Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/ard.62.9.901","article-title":"European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria","volume":"62","author":"Valentini","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib16","first-page":"S97","article-title":"Assessment of sensitivity to change of the disease activity score in systemicsclerosis","volume":"32","author":"Decuman","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib17","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3899\/jrheum.090919","article-title":"The association between disease activity and duration in systemic sclerosis","volume":"37","author":"Walker","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/ard.43.6.794","article-title":"Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration","volume":"43","author":"Furst","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.semarthrit.2011.10.003","article-title":"Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritis","volume":"41","author":"Clements","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib20","first-page":"1038","article-title":"Pulmonary arterial histology and morphometry in systemic sclerosis: a case\u2013control autopsy study","volume":"16","author":"al-Sabbagh","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0126707","article-title":"Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy","volume":"10","author":"Mueller","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.1780341105","article-title":"Cardiac score: a semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis","volume":"34","author":"Clements","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1164\/ajrccm\/144.3_Pt_1.706","article-title":"Structural features of interstitial lung disease in systemic sclerosis","volume":"144","author":"Harrison","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/543704","article-title":"Scleroderma renal crisis: a pathology perspective","volume":"2010","author":"Batal","year":"2010","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib25","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/rheumatology\/kes185","article-title":"Eustar, International Classification of Functioning, Disability and Health Core Set construction in systemic sclerosis and other rheumatic diseases: a EUSTAR initiative","volume":"51","author":"Saketkoo","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00296-005-0058-3","article-title":"The use of the hand anatomic index to assess deformity and impaired function in systemic sclerosis","volume":"26","author":"Roberts-Thomson","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00296-008-0777-3","article-title":"A modified hand anatomic index to assesss hand deformity in scleroderma","volume":"29","author":"Roberts-Thomson","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1422.029","article-title":"Systemic sclerosis-associated myopathy","volume":"1108","author":"Ranque","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib29","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1186\/ar3888","article-title":"Aldolase predicts subsequent myopathy occurrence in systemic sclerosis","volume":"14","author":"Toledano","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib30","first-page":"S28","article-title":"Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis","volume":"28","author":"Torok","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib31","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib32","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/acr.20320","article-title":"Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study","volume":"62","author":"Au","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib33","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/1529-0131(199911)42:11<2372::AID-ANR16>3.0.CO;2-J","article-title":"Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis","volume":"42","author":"Clements","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/1529-0131(200012)13:6<382::AID-ART8>3.0.CO;2-9","article-title":"Validity of HAMIS: a test of hand mobility in scleroderma","volume":"13","author":"Sandqvist","year":"2000","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/03009740802695466","article-title":"A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis","volume":"38","author":"Sandqvist","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1529-0131(200012)13:6<369::AID-ART6>3.0.CO;2-X","article-title":"Hand Mobility in Scleroderma (HAMIS) test: the reliability of a novel hand function test","volume":"13","author":"Sandqvist","year":"2000","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/03009742.2012.756928","article-title":"Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis","volume":"42","author":"Hesselstrand","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semarthrit.2007.01.005","article-title":"Update on indices of disease activity in systemic sclerosis","volume":"37","author":"Hudson","year":"2007","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl. 5","key":"10.1016\/j.semarthrit.2016.07.010_bib39","doi-asserted-by":"crossref","first-page":"Sv46","DOI":"10.1093\/rheumatology\/ken310","article-title":"Digital ulcers and outcomes assessment in scleroderma","volume":"47","author":"Matucci-Cerinic","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib40","first-page":"2477","article-title":"Scleroderma\u2014developing measures of response","volume":"32","author":"Furst","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib41","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/rheumatology\/kev002","article-title":"Prediction and impact of attacks of Raynaud\u2019s phenomenon, as judged by patient perception","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib42","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/rheumatology\/ket153","article-title":"State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?","volume":"52","author":"Cutolo","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib43","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1586\/1744666X.2013.849198","article-title":"A systematic overview on the use and relevance of capillaroscopy in systemic sclerosis","volume":"9","author":"Ingegnoli","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib44","first-page":"S103","article-title":"Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis","volume":"31","author":"Kayser","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib45","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13075-014-0462-8","article-title":"Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis","volume":"16","author":"Sambataro","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib46","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/ar3748","article-title":"Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group","volume":"14","author":"Foocharoen","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejim.2010.09.013","article-title":"Erectile dysfunction of sclerodermic patients correlates with digital vascular damage","volume":"22","author":"Rosato","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/art.1780220205","article-title":"Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma","volume":"22","author":"Rodnan","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib49","doi-asserted-by":"crossref","first-page":"652","DOI":"10.7326\/0003-4819-97-5-652","article-title":"d-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis","volume":"97","author":"Steen","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib50","first-page":"1277","article-title":"Is it possible to reduce observer variability in skin score assessment of scleroderma?","volume":"22","author":"Silman","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib51","first-page":"367","article-title":"A modified scleroderma skin scoring method","volume":"4","author":"Kahaleh","year":"1986","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.1992.01680130051005","article-title":"Treatment of systemic sclerosis with extracorporeal photochemotherapy: results of a multicenter trial","volume":"128","author":"Rook","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib53","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/art.1780340315","article-title":"A double-blind randomized controlled trial of ketotifen versus placebo in early diffuse scleroderma","volume":"34","author":"Gruber","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease damage: a proof-of-concept study","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/rheumatology\/ken309","article-title":"Skin involvement in systemic sclerosis","volume":"47","author":"Czirj\u00e1k","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib56","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/ard.2009.127621","article-title":"Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma","volume":"70","author":"Domsic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib57","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.22747","article-title":"Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody","volume":"56","author":"Perera","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib58","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/art.22721","article-title":"Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model","volume":"56","author":"Shand","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib59","first-page":"1194","article-title":"Systemic sclerosis\u2014continuing progress in developing clinical measures of response","volume":"34","author":"Furst","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib60","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1756-185X.12106","article-title":"A systematic review of ultrasonography as an outcome measure of skin involvement in systemic sclerosis","volume":"16","author":"Ch\u2019ng","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib61","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/rheumatology\/keq024","article-title":"Assessment of tissue fibrosis in skin biopsies from patients with systemic sclerosis employing confocal laser scanning microscopy: an objective outcome measure for clinical trials?","volume":"49","author":"Busquets","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib62","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2009.120303","article-title":"Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group","volume":"69","author":"Avouac","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3899\/jrheum.090661","article-title":"Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group","volume":"37","author":"Kowal-Bielecka","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib64","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0735-1097(03)00121-9","article-title":"Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension","volume":"41","author":"Galie","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(81)90256-4","article-title":"The relationship of arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS)","volume":"71","author":"Clements","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib66","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0002-9343(88)90305-1","article-title":"Prognostic importance of cardiac arrhythmias in systemic sclerosis","volume":"84","author":"Kostis","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7326\/0003-4819-94-1-38","article-title":"The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis","volume":"94","author":"Roberts","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib68","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib69","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/art.30467","article-title":"Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group","volume":"63","author":"Khanna","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib70","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 3","key":"10.1016\/j.semarthrit.2016.07.010_bib71","first-page":"Siii40","article-title":"Pulmonary complications: one of the most challenging complications of systemic sclerosis","volume":"48","author":"Wells","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib72","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1445-5994.2009.01990.x","article-title":"T. Pulmonary Interstitial Vascular Organisational, Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians","volume":"40","author":"Mangat","year":"2010","journal-title":"Intern Med J"},{"issue":"Suppl. 5","key":"10.1016\/j.semarthrit.2016.07.010_bib73","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1093\/rheumatology\/ken311","article-title":"Outcome measures in the lung","volume":"47","author":"Wells","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib74","first-page":"1","article-title":"High resolution computed tomography scoring systems for evaluating interstitial lung disease in systemic sclerosis patients","volume":"S1","author":"Assayag","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib75","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/thx.47.9.738","article-title":"High resolution computed tomography as a predictor of lung histology in systemic sclerosis","volume":"47","author":"Wells","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib76","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0002-9343(99)80157-0","article-title":"Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis","volume":"99","author":"Morelli","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib77","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/s10165-010-0403-6","article-title":"Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up","volume":"21","author":"Tochimoto","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib78","first-page":"1520","article-title":"High resolution computed tomography in early scleroderma lung disease","volume":"18","author":"Warrick","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib79","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.07-2444","article-title":"High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease","volume":"134","author":"Goldin","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib80","first-page":"258","article-title":"Interstitial lung disease in systemic sclerosis","volume":"44","author":"Ooi","year":"2003","journal-title":"Acta Radiol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib81","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.carj.2010.02.006","article-title":"Predictors of pulmonary hypertension on high-resolution computed tomography of the chest in systemic sclerosis: a retrospective analysis","volume":"61","author":"Pandey","year":"2010","journal-title":"Can Assoc Radiol J"},{"issue":"Suppl. 3","key":"10.1016\/j.semarthrit.2016.07.010_bib82","article-title":"Quantification of interstitial pulmonary fibrosis in systemic sclerosis using an open-source dicom viewer software (OSIRIX)","volume":"71","author":"Carotti","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib83","first-page":"W74","article-title":"Histogram-based quantification of fibrosis in systemic sclerosis on sequential low dose HRCT of 9?CT slices","volume":"28","author":"Nguyen-Kim","year":"2013","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/rheumatology\/kes289","article-title":"Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease","volume":"52","author":"Moore","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib85","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1183\/16000617.00002915","article-title":"Interstitial lung disease in systemic sclerosis: where do we stand?","volume":"24","author":"Cappelli","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib86","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/rheumatology\/kep263","article-title":"Ultrasound lung comets in systemic sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosis","volume":"48","author":"Gargani","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib87","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/thoraxjnl-2013-204202","article-title":"Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials","volume":"69","author":"Saketkoo","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11926-011-0217-3","article-title":"Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management","volume":"14","author":"Gyger","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib89","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.24730","article-title":"Reliability and validity of the University of California, Los Aangeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument","volume":"61","author":"Khanna","year":"2009","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib90","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.clnu.2012.02.010","article-title":"Disease-related malnutrition in outpatients with systemic sclerosis","volume":"31","author":"Caporali","year":"2012","journal-title":"Clin Nutr"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib91","first-page":"2477","article-title":"Scleroderma\u2014developing measures of response","volume":"32","author":"Furst","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib92","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis","volume":"133","author":"Steen","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib93","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/ndt\/gfq861","article-title":"End-stage kidney disease due to scleroderma\u2014outcomes in 127 consecutive ANZDATA registry cases","volume":"26","author":"Siva","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib94","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/BOR.0b013e3283588dcf","article-title":"Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management","volume":"24","author":"Shanmugam","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib95","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma","volume":"32","author":"Steen","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib96","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","article-title":"Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being","volume":"29","author":"Medsger","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib97","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/art.22468","article-title":"Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), systemic sclerosis HAQ, and medical outcomes study 36-item short form health survey","volume":"57","author":"Rannou","year":"2007","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.07.010_bib98","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/rheumatology\/ket377","article-title":"Cardiac arrhythmias and conduction defects in systemic sclerosis","volume":"53","author":"Vacca","year":"2014","journal-title":"Rheumatology (Oxford)"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216301251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216301251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T08:06:17Z","timestamp":1655366777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017216301251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0049017216301251"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.07.010","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measures of disease status in systemic sclerosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}